key: cord-0851970-wt49qa1p
authors: rehman, marium; Kumar, Dilpat; Armughan Ali, Muhammad; Hooks, Brandon
title: PULMONARY CAVITATION AS A SEQUELAE OF COVID-19 PNEUMONIA: AN UNCOMMON PHENOMENON
date: 2021-10-31
journal: Chest
DOI: 10.1016/j.chest.2021.07.1587
sha: 2a49660f053ee200afdb6221e7158aee8db5f7ff
doc_id: 851970
cord_uid: wt49qa1p

nan

CASE PRESENTATION: A 29-year-old man presented to emergency department with hemoptysis and epistaxis for 3-days. He was diagnosed with COVID-19 pneumonia two months prior, which was treated with 5-days of azithromycin and 7-days of dexamethasone. He denied weight loss, night sweats, recent travel and tuberculosis exposure. On presentation, he was in no acute distress and was saturating >95%. Repeat SARS-CoV2 testing was negative. Blood work comprising of complete blood count, comprehensive metabolic panel, and coagulation panel was normal. Blood and respiratory cultures had no growth. Chest X-ray showed air fluid level in the left lower lobe prompting concern for pulmonary abscess. Computed tomography (CT) of chest with contrast showed left sided cavitary lesion measuring 4.2 x 4.6 x. 4.6 cm along inferior left fissure in the left upper lobe with mural nodularity and air fluid level. Patient was discharged with close pulmonology follow up. Subsequent workup with acid fast bacillus (AFB) smear and culture, QuantiFERON TB Gold, fungal antibodies, (1,3) Beta-D-glucan, galactomannan antigen and antineutrophil cytoplasmic antibody screen was negative. Bronchoscopy with bronchoalveolar lavage revealed a reddish, cloudy fluid with numerous red and white blood cells. Bacterial, AFB and fungal cultures were negative. Transbronchial biopsy did not reveal malignant cells. Given reported cases of aspergillosis causing cavitary lesions in patients with COVID-19 disease, he was started on fluconazole and noticed significant improvement in the symptoms. Repeat CT chest is scheduled to demonstrate improvement of the cavitation.

DISCUSSION: This case demonstrates a pulmonary cavitary lesion as a unique complication of COVID-19 disease. Patient had an otherwise negative work-up which means that the cavitation may have been a sequelae of COVID-19 pneumonia. Few cases have reported pulmonary cavitation as late complication of severe COVID-19 pneumonia [1,2]; however, our patient had mild symptoms and did not require hospitalization. Coronavirus associated pulmonary aspergillosis (CAPA) has been cited in literature complicating severe viral illness [3] . Treatment with azoles has been shown to be beneficial in such cases. Additional studies are needed to further elucidate the pathophysiology of these cavitary lesions in COVID-19 disease and explore management options.

CONCLUSIONS: Physicians should be aware of cavitary lesions as possible complication of COVID-19 disease with consideration of aspergillosis as an important etiology to rule out.

Pulmonary cavitation: an underrecognized late complication of severe COVID-19 lung disease

Delayed pulmonary abscess following COVID-19 pneumonia: A case report